123 related articles for article (PubMed ID: 38049114)
1. Dosing, Monitoring, Blood Product Utilization, and Thromboembolic Complications of Four-Factor Prothrombin Complex Concentrate as Part of an Institutional Protocol in Pediatric Cardiac Surgery: A Retrospective Cohort Study.
Kiskaddon AL; Goldenberg NA; Fierstein JL; Miller A; Quintessenza JA; Kartha VM
Semin Thromb Hemost; 2023 Dec; ():. PubMed ID: 38049114
[TBL] [Abstract][Full Text] [Related]
2. Use of four-factor prothrombin complex concentrate (4F-PCC) for management of bleeding not associated with therapeutic anticoagulant use.
Uttaro E; Young MR; Falvey J; Corvelli JM; Acquisto NM
Transfus Apher Sci; 2023 Oct; 62(5):103759. PubMed ID: 37453907
[TBL] [Abstract][Full Text] [Related]
3. Utilization and safety of off-label prothrombin complex concentrate (four-factor prothrombin complex concentrate) in a surgical population.
Sandquist K; Kaucher K; Newell J; Sarangarm P; Burnett A
Blood Coagul Fibrinolysis; 2024 Apr; 35(3):124-128. PubMed ID: 38477833
[TBL] [Abstract][Full Text] [Related]
4. Intraoperative Administration of 4-Factor Prothrombin Complex Concentrate Reduces Blood Requirements in Cardiac Transplantation.
Sun GH; Patel V; Moreno-Duarte I; Zahedi F; Ursprung E; Couper G; Chen FY; Welsby IJ; Comenzo R; Kao G; Cobey FC
J Cardiothorac Vasc Anesth; 2018 Feb; 32(1):161-167. PubMed ID: 29198634
[TBL] [Abstract][Full Text] [Related]
5. Comparison of 4-Factor Prothrombin Complex Concentrate With Frozen Plasma for Management of Hemorrhage During and After Cardiac Surgery: A Randomized Pilot Trial.
Karkouti K; Bartoszko J; Grewal D; Bingley C; Armali C; Carroll J; Hucke HP; Kron A; McCluskey SA; Rao V; Callum J
JAMA Netw Open; 2021 Apr; 4(4):e213936. PubMed ID: 33792729
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of four-factor prothrombin complex concentrate fixed, weight-based dosing for reversal of warfarin anticoagulation.
Endres K; St Bernard R; Chin-Yee I; Hsia C; Lazo-Langner A
Hematology; 2020 Dec; 25(1):489-493. PubMed ID: 33317427
[TBL] [Abstract][Full Text] [Related]
7. A Comparison of Prothrombin Complex Concentrate and Recombinant Activated Factor VII for the Management of Bleeding With Cardiac Surgery.
Katz A; Ahuja T; Arnouk S; Lewis TC; Marsh K; Papadopoulos J; Merchan C
J Intensive Care Med; 2022 Feb; 37(2):231-239. PubMed ID: 33402016
[TBL] [Abstract][Full Text] [Related]
8. Four-factor prothrombin complex concentrate for life-threatening bleeds or emergent surgery: A retrospective evaluation.
Sin JH; Berger K; Lesch CA
J Crit Care; 2016 Dec; 36():166-172. PubMed ID: 27546767
[TBL] [Abstract][Full Text] [Related]
9. Three-factor prothrombin complex concentrates for refractory bleeding after cardiovascular surgery within an algorithmic approach to haemostasis.
Hashmi NK; Ghadimi K; Srinivasan AJ; Li YJ; Raiff RD; Gaca JG; Root AG; Barac YD; Ortel TL; Levy JH; Welsby IJ
Vox Sang; 2019 May; 114(4):374-385. PubMed ID: 30937927
[TBL] [Abstract][Full Text] [Related]
10. Utilization and safety of off-label prothrombin complex concentrate (4F-PCC) in a nonsurgical population.
Sandquist K; Kaucher K; Newell J; Sarangarm P; Burnett A
Blood Coagul Fibrinolysis; 2024 Jun; 35(4):161-166. PubMed ID: 38477829
[TBL] [Abstract][Full Text] [Related]
11. Thromboembolic Risk of 4-Factor Prothrombin Complex Concentrate versus Fresh Frozen Plasma for Urgent Warfarin Reversal in the Emergency Department.
Maguire M; Fuh L; Goldstein JN; Marshall AL; Levine M; Howell ML; Parry BA; Rosovsky R; Hayes BD
West J Emerg Med; 2019 Jul; 20(4):619-625. PubMed ID: 31316701
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and Safety of Early Administration of 4-Factor Prothrombin Complex Concentrate in Patients With Trauma at Risk of Massive Transfusion: The PROCOAG Randomized Clinical Trial.
Bouzat P; Charbit J; Abback PS; Huet-Garrigue D; Delhaye N; Leone M; Marcotte G; David JS; Levrat A; Asehnoune K; Pottecher J; Duranteau J; Courvalin E; Adolle A; Sourd D; Bosson JL; Riou B; Gauss T; Payen JF;
JAMA; 2023 Apr; 329(16):1367-1375. PubMed ID: 36942533
[TBL] [Abstract][Full Text] [Related]
13. Andexanet alfa versus four-factor prothrombin complex concentrate for the reversal of apixaban- or rivaroxaban-associated intracranial hemorrhages.
Pham H; Medford WG; Horst S; Levesque M; Ragoonanan D; Price C; Colbassani H; Piper K; Chastain K
Am J Emerg Med; 2022 May; 55():38-44. PubMed ID: 35272069
[TBL] [Abstract][Full Text] [Related]
14. Incidence of thromboembolic events following administration of four-factor prothrombin complex concentrate (4F-PCC) for oral anticoagulation reversal.
Makhoul T; Kelly G; Kersten B; Nadler M; Zammit CG; Jones CMC; Scott R; Acquisto NM
Thromb Res; 2020 Oct; 194():158-164. PubMed ID: 32788109
[TBL] [Abstract][Full Text] [Related]
15. Initial Experience of the Use of 3-Factor Prothrombin Complex Concentrate and Thromboembolic Complications After Cardiac Surgery.
Zweng I; Galvin S; Robbins R; Bellomo R; Hart GK; Seevanayagam S; Matalanis G
Heart Lung Circ; 2019 Nov; 28(11):1706-1713. PubMed ID: 30309711
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of a 4-factor prothrombin complex concentrate in patients on vitamin K antagonists presenting with major bleeding: a randomized, plasma-controlled, phase IIIb study.
Sarode R; Milling TJ; Refaai MA; Mangione A; Schneider A; Durn BL; Goldstein JN
Circulation; 2013 Sep; 128(11):1234-43. PubMed ID: 23935011
[TBL] [Abstract][Full Text] [Related]
17. Impact of a Pharmacist-Driven Prothrombin Complex Concentrate Protocol on Time to Administration in Patients with Warfarin-associated Intracranial Hemorrhage.
Corio JL; Sin JH; Hayes BD; Goldstein JN; Fuh L
West J Emerg Med; 2018 Sep; 19(5):849-854. PubMed ID: 30202498
[TBL] [Abstract][Full Text] [Related]
18. Three- versus four-factor prothrombin complex concentrate for the reversal of warfarin-induced bleeding.
Holt T; Taylor S; Abraham P; Mcmillian W; Harris S; Curtis J; Elder T
Int J Crit Illn Inj Sci; 2018; 8(1):36-40. PubMed ID: 29619338
[TBL] [Abstract][Full Text] [Related]
19. Thromboembolic Events After Vitamin K Antagonist Reversal With 4-Factor Prothrombin Complex Concentrate: Exploratory Analyses of Two Randomized, Plasma-Controlled Studies.
Milling TJ; Refaai MA; Goldstein JN; Schneider A; Omert L; Harman A; Lee ML; Sarode R
Ann Emerg Med; 2016 Jan; 67(1):96-105.e5. PubMed ID: 26094105
[TBL] [Abstract][Full Text] [Related]
20. Clinical utilization of four-factor prothrombin complex concentrate: a retrospective single center study.
Naeem Z; Allan S; Hernandez A; Galanakis DK; Singer AJ
Clin Exp Emerg Med; 2021 Jun; 8(2):75-81. PubMed ID: 34237811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
